DRIVAPEX-0.5 TABLETS
DRIVAPEX-0.5 TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | DRIVAPEX-0.5 Tablets |
| Form | Tablets |
| Key Ingredient | Pramipexole Dihydrochloride 0.5 mg |
| Core Benefits | Improves motor function, reduces tremors and stiffness |
| Mechanism of Action | Dopamine receptor agonist – mimics dopamine in the brain |
| Support Areas | Parkinson’s disease, Restless Legs Syndrome (RLS) |
| Recommended Usage | As prescribed by a neurologist; usually once or twice daily |
Composition: Pramipexole 0.5mg Packing: 10X10 Alu-Alu
Description : DRIVAPEX-0.5 Tablets contain Pramipexole Dihydrochloride 0.5 mg, a dopamine agonist used primarily in the management of Parkinson’s disease and Restless Legs Syndrome (RLS). It works by stimulating dopamine receptors in the brain, improving movement control and reducing symptoms like tremors, stiffness, and slowness. DRIVAPEX-0.5 offers effective symptom relief with a favorable safety profile when taken under neurological supervision. It is especially beneficial in early-stage Parkinsonism or as an add-on therapy in advanced stages.
Send Enquiry & Get Best Quote
Fill out the form below to connect with our experts to get best price and deals on our bulk products
Expertise You Can Count On
At Chemo Biologicals, trust is built on decades of proven expertise. With over 43 years of industry experience, we bring unmatched knowledge, precision, and professionalism to every aspect of our operations. Our team of experts—ranging from skilled pharmacists to regulatory specialists—ensures that every product meets the highest standards of quality, safety, and compliance.
Whether you’re partnering with us for PCD Pharma Franchise or Third-Party Manufacturing, you can rely on our deep understanding of the pharmaceutical landscape, robust infrastructure, and ethical business approach. We don’t just deliver medicines—we deliver confidence, consistency, and care.
Choose Chemo Biologicals — where experience drives excellence and expertise earns your trust.
